These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9203190

  • 1. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Tümer N, Cakar N, Ozkaya N.
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [Abstract] [Full Text] [Related]

  • 3. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Aug; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 5. Human erythropoietin in children undergoing continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1992 Feb; 34(1):36-41. PubMed ID: 1580151
    [Abstract] [Full Text] [Related]

  • 6. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Sieniawska M, Roszkowska-Blaim M.
    Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294
    [Abstract] [Full Text] [Related]

  • 7. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L, Salusky IB, Fine RN.
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y, Ito K.
    Adv Perit Dial; 1992 Apr; 8():448-52. PubMed ID: 1361845
    [Abstract] [Full Text] [Related]

  • 9. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Apr; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 10. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ, Gaspar A, Santana A, Bruges M, Simões J.
    Perit Dial Int; 1993 Apr; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [Abstract] [Full Text] [Related]

  • 11. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
    Lai KN, Lui SF, Leung JC, Law E, Nicholls MG.
    Nephron; 1991 Apr; 57(4):394-400. PubMed ID: 1828543
    [Abstract] [Full Text] [Related]

  • 12. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
    Perit Dial Int; 1992 Apr; 12(4):378-83. PubMed ID: 1420497
    [Abstract] [Full Text] [Related]

  • 13. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Nov; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 16. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 Nov; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
    Aufricht C, Marik JL, Ettenger RB.
    Pediatr Nephrol; 1998 Jan; 12(1):10-3. PubMed ID: 9502558
    [Abstract] [Full Text] [Related]

  • 18. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF, Mora C, Macía M, García J.
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [Abstract] [Full Text] [Related]

  • 19. Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME.
    Am J Kidney Dis; 1991 Oct; 18(4):446-50. PubMed ID: 1928063
    [Abstract] [Full Text] [Related]

  • 20. The beneficial effect of low initial dose and gradual increase of erythropoietin treatment in hemodialysis patients.
    Walter J, Gål J, Taraba I.
    Artif Organs; 1995 Jan; 19(1):76-80. PubMed ID: 7741644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.